Do you have Plaque Psoriasis?

A doctor in your area is conducting a clinical study to assess the safety and effectiveness of a medication in patients with plaque psoriasis. In this study, patients will switch from Enbrel® to the study medication, which is FDA-approved to treat chronic severe plaque psoriasis but has not been studied in psoriasis patients who are switching treatments.

To qualify for participation in this research study, you must:

Be between the ages of 18 and 75 years old
Have been diagnosed with plaque psoriasisHave been treated with Enbrel® (etanercept) for at least the past 4 months
Currently have psoriatic lesions

Please call Solano Clinical Research toll free: 1(877) 449-7546 ext. 223 for more information.

If you are interested in participating as a volunteer for a clinical study in dermatology, vaccines or women's health, please call (877) 449-7546 ext. 223.

Would you like to learn more? Check out the Volunteer FAQs or contact us if you have questions.

Solano Clinical Research, located in Vallejo, California, is an independent investigative site fully dedicated to clinical research, with expertise in conducting Phase I - IV studies in dermatology, vaccines, and women's health. We help you gain rapid market approval by starting your study on time, meeting or exceeding your enrollment goals, and providing you with clean data.